Form 8-K Seres Therapeutics, Inc. For: Aug 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Seres Therapeutics (MCRB) Posts Q2 Loss of $1.45/Share
August 6, 2015 7:38 AM EDTSeres Therapeutics (NASDAQ: MCRB) reported Q2 EPS of ($1.45), $1.15 worse than the analyst estimate of ($0.30).
For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.
... More